EP3982960
Meðhöndlun á arfgengum ofsabjúgi
:
EP einkaleyfi í gildi á Íslandi:
15.6.2020:
28.6.2023:
20734283.3
:
28.8.2023:
15.9.2023
:
14.6.2040:
14.6.2026:
30.6.2026
:
TREATMENTS OF HEREDITARY ANGIOEDEMA
15.6.2020
28.6.2023
28.8.2023
15.9.2023
14.6.2026
:
Kalvista Pharmaceuticals Limited:
Porton Science Park Bybrook Road, Porton Down, Salisbury SP4 0BF Wiltshire, GB
:
FEENER, Edward Paul:
North Reading, Massachusetts 01864, US
:
MARSH, Sally Louise:
Salisbury, Wiltshire SP4 0BF, GB
:
MAETZEL, Andreas:
Chapel Hill, North Carolina 27516, US
:
SMITH, Michael David:
Salt Lake City, Utah 84109, US
:
YEA, Christopher Martyn:
Salisbury, Wiltshire SP4 0BF, GB
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201962861725 P:
14.6.2019:
US
:
201910116:
15.7.2019:
GB
:
GB2020051439:
15.6.2020
:
A61K 31/444, A61P 7/00
: 5
: 7.5.2024
: 14.6.2025
: Árnason Faktor ehf.
: 6
: 2.6.2025
: 14.6.2026
: Árnason Faktor ehf.